SCHEMBL30400522

SCHEMBL30400522

Cn1nnc2ccc(-c3c[nH]c4ncc(C(=O)Nc5cnn(C6CCNCC6)c5)cc34)cc21

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 6/20 0.48
▸ GSK3B P49841 4/20 0.48
▸ CLK1 P49759 2/20 0.45
▸ DYRK1B Q9Y463 2/20 0.45
▸ MAPK7 Q13164 1/20 0.43
▸ PAK1 Q13153 11/20 0.43
▸ PAK4 O96013 2/20 0.42
▸ DYRK2 Q92630 1/20 0.42
▸ NTRK1 P04629 1/20 0.40
▸ SIK1 P57059 1/20 0.39
▸ SIK3 Q9Y2K2 1/20 0.39
▸ CLK2 P49760 1/20 0.39
▸ CLK3 P49761 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26175090 1.00 DYRK1A (0.48) DYRK1AGSK3BCLK1DYRK1BMAPK7
SCHEMBL26175131 0.93 DYRK1A (0.48) DYRK1AGSK3BCLK1DYRK1BMAPK7
SCHEMBL30400661 0.93 DYRK1A (0.48) DYRK1AGSK3BCLK1DYRK1BMAPK7
SCHEMBL30399658 0.86 DYRK1A (0.48) DYRK1AGSK3BCLK1DYRK1BMAPK7
SCHEMBL26175109 0.86 DYRK1A (0.48) DYRK1AGSK3BCLK1DYRK1BMAPK7
SCHEMBL30399310 0.86 DYRK1A (0.48) DYRK1AGSK3BCLK1DYRK1BMAPK7
SCHEMBL26175076 0.86 DYRK1A (0.48) DYRK1AGSK3BCLK1DYRK1BMAPK7
SCHEMBL30400272 0.83 EGFR (0.48) DYRK1AGSK3BCLK1DYRK1BMAPK7
SCHEMBL30399049 0.83 DYRK1A (0.46) DYRK1AGSK3BCLK1DYRK1BMAPK7
SCHEMBL26175108 0.83 EGFR (0.48) DYRK1AGSK3BCLK1DYRK1BMAPK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4415817-A1 1H-PYRROLO[2,3-B]PYRIDINES AS DYRK1A INHIBITORS BioSplice Therapeutics, Inc. (US) 2024-08-21 — — EP claimed
WO-2023064349-A1 1H-PYRROLO[2,3-B]PYRIDINES AS DYRK1A INHIBITORS BIOSPLICE THERAPEUTICS, INC. (US) 2023-04-20 — — WO claimed
Send feedback